MCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors
- 31 December 1992
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 50 (8), 599-605
- https://doi.org/10.1016/0024-3205(92)90372-v
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized ratsEuropean Journal of Pharmacology, 1990
- Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity studyEuropean Journal of Pharmacology, 1989
- Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortexEuropean Journal of Pharmacology, 1989
- [3H]Quipazine labels 5-HT3 recognition sites in rat cortical membranesEuropean Journal of Pharmacology, 1988
- Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonistsNeuropharmacology, 1987
- The pharmacology and function of 5-HT3receptorsTrends in Neurosciences, 1986
- 5-HT1 and 5-HT2: binding characteristics of some quipazine analogsJournal of Medicinal Chemistry, 1986
- Further evidence that the serotonin receptor in the rat stomach fundus is not 5HT1A or 5HT1BLife Sciences, 1986
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazineLife Sciences, 1983